Krajcsir, B.; Pócsi, M.; Fejes, Z.; Nagy, B., Jr.; Kappelmayer, J.; Beke Debreceni, I.
Ponatinib Induces a Procoagulant Phenotype in Human Coronary Endothelial Cells via Inducing Apoptosis. Pharmaceutics 2024, 16, 559.
https://doi.org/10.3390/pharmaceutics16040559
AMA Style
Krajcsir B, Pócsi M, Fejes Z, Nagy B Jr., Kappelmayer J, Beke Debreceni I.
Ponatinib Induces a Procoagulant Phenotype in Human Coronary Endothelial Cells via Inducing Apoptosis. Pharmaceutics. 2024; 16(4):559.
https://doi.org/10.3390/pharmaceutics16040559
Chicago/Turabian Style
Krajcsir, Bálint, Marianna Pócsi, Zsolt Fejes, Béla Nagy, Jr., János Kappelmayer, and Ildikó Beke Debreceni.
2024. "Ponatinib Induces a Procoagulant Phenotype in Human Coronary Endothelial Cells via Inducing Apoptosis" Pharmaceutics 16, no. 4: 559.
https://doi.org/10.3390/pharmaceutics16040559
APA Style
Krajcsir, B., Pócsi, M., Fejes, Z., Nagy, B., Jr., Kappelmayer, J., & Beke Debreceni, I.
(2024). Ponatinib Induces a Procoagulant Phenotype in Human Coronary Endothelial Cells via Inducing Apoptosis. Pharmaceutics, 16(4), 559.
https://doi.org/10.3390/pharmaceutics16040559